Chronic Low Back Pain Clinical Trial
Official title:
Effects of Motivational Interviewing on Self-Efficacy and Standardized Low Back Pain Outcomes in Patients With Chronic Back Pain
The majority of the study consists of standard of care treatment for people with low back
pain that has lasted more than three months. Half of the participants in the study will
receive physical therapy from physical therapists that have received additional training in
an educational technique. In order to determine if there is a difference in patient outcome
when the educational technique is used, you will be asked to complete five short surveys
before receiving physical therapy (10 minutes total). A sample of the physical therapy
sessions using the educational technique will be videotaped. The videotape will be of the
physical therapist to prove they did use the educational technique, not of you the
participant in the study. You will remain anonymous and will not be used and the tape will
not be used for publication or presentation purposes. You will also be asked to complete one
survey after participating in physical therapy (2 minutes), and all five short surveys (10
minutes total) six weeks after your last physical therapy session.
You will be put in one of 2 groups by chance (as in the flip of a coin). A computerized
selection process will be used to assign participants to the study. You will not know if you
are in the study group or the non-study group.
This is a pilot study to evaluate the impact of MI on self-efficacy and outcomes for chronic
low back pain.
Design Prospective randomized, single blind pilot, controlled study. Patients will be
referred from E10 and the Spine Center by contacting the study coordinator. The Coordinator
will meet with potential participants, determine if they meet the inclusion and exclusion
criteria, obtain informed consent, assess self-efficacy using the Stanford Self efficacy
instrument, use en bloc randomization for self-efficacy to the experimental and control
group. They will then complete the SF-12, a VAS pain scale, and the Roland and Morris
Disability questionnaire, a few questions about employment status and 1 question about
satisfaction with care.
The experimental group(goal n=20) will be treated by physical therapists that have been
trained in motivational interviewing techniques by a PhD and a sample of these sessions will
be videotaped for validation purposes. The control group(goal n=20) will receive PT from any
PT as per the normal standard of care.
Both the experimental and control group will complete an additional self-efficacy instrument
prior to leaving. Six weeks after the patients participate in a motivational interview
session they will be mailed a repeat of all of the previously mentioned instruments
including the self-efficacy tool. Patients who return the completed instruments will receive
forty dollars. If effect size is small, this pilot study will be underpowered, if a
clinically significant trend is observed additional funding will be sought and the
experimental and control n will be expanded to 64.
Setting Tertiary academic medical center Participants Referrals from a Spine Center, or a
large outpatient Physical Medicine and Rehabilitation practice with at least three months of
chronic low back pain.
Primary Outcome Measure Self-efficacy for Managing Chronic disease 6-Item scale
Main Outcome Measures Roland and Morris Disability Questionnaire Pain VAS Satisfaction with
care question Disability status question SF-12 Exclusion Criteria Medical /legal involvement
Active workers compensation Infection or tumor in spine Active systemic disease in the
lumbar spine Multiple other musculoskeletal problems that require Treatment Patients
receiving more than 2 PT sessions
Inclusion Criteria Three or more months of low back pain Ability to read, write and speak
English
;
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |